1. Novel anti-Plasmodial hits identified by virtual screening of the ZINC database
- Author
-
Kelly Chibale, Ana S. Newton, Philip J. Rosenthal, Rui Moreira, Rita C. Guedes, Grace Mugumbate, and Jiri Gut
- Subjects
Proteases ,Databases, Factual ,medicine.medical_treatment ,In silico ,Plasmodium falciparum ,Biology ,Small Molecule Libraries ,Antimalarials ,Chloroquine ,Drug Discovery ,medicine ,Food vacuole ,Animals ,Humans ,Computer Simulation ,Protease Inhibitors ,Physical and Theoretical Chemistry ,Virtual screening ,Protease ,biology.organism_classification ,Cysteine protease ,Drug Resistance, Multiple ,Malaria ,Computer Science Applications ,Cysteine Endopeptidases ,Biochemistry ,medicine.drug - Abstract
Increased resistance of Plasmodium falciparum to most available drugs challenges the control of malaria. Studies with protease inhibitors have suggested important roles for the falcipain family of cysteine proteases. These enzymes act in concert with other proteases to hydrolyze host erythrocyte hemoglobin in the parasite food vacuole. In order to find potential new antimalarial drugs, we screened in silico the ZINC database using two different protocols involving structure- and ligand-based methodologies. Our search identified 19 novel low micromolar inhibitors of cultured chloroquine resistant P. falciparum. The most active compound presented an IC50 value of 0.5 μM against cultured parasites and it also inhibited the cysteine protease falcipain-2 (IC50 = 25.5 μM). These results identify novel classes of antimalarials that are structurally different from those currently in use and which can be further derivatized to deliver leads suitable for optimisation.
- Published
- 2013
- Full Text
- View/download PDF